Pages that link to "Q34513753"
Jump to navigation
Jump to search
The following pages link to Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies (Q34513753):
Displaying 50 items.
- Meta-analysis of risk factors for Parkinson's disease dementia (Q26743404) (← links)
- Cerebrospinal Fluid Amyloid β1-42, Tau, and Alpha-Synuclein Predict the Heterogeneous Progression of Cognitive Dysfunction in Parkinson's Disease (Q26744782) (← links)
- Toward precision medicine in Parkinson's disease (Q26764954) (← links)
- Cues and Attention in Parkinsonian Gait: Potential Mechanisms and Future Directions (Q26772362) (← links)
- Many Faces of Parkinson's Disease: Non-Motor Symptoms of Parkinson's Disease (Q28081355) (← links)
- What is the Clinical Significance of Cerebrospinal Fluid Biomarkers in Parkinson's disease? Is the Significance Diagnostic or Prognostic? (Q28083203) (← links)
- Rational pharmacological approaches for cognitive dysfunction and depression in Parkinson's disease (Q28084380) (← links)
- Cognitive function in early Parkinson's disease: a population-based study (Q28249085) (← links)
- Meeting report: consensus statement-Parkinson's disease and the environment: collaborative on health and the environment and Parkinson's Action Network (CHE PAN) conference 26-28 June 2007 (Q28387116) (← links)
- Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson's Disease. (Q30276531) (← links)
- Cortical Implications of Advancing Age and Disease Duration in Parkinson's Disease Patients with Postural Instability and Gait Dysfunction (Q30276836) (← links)
- Differential susceptibility to motor impulsivity among functional subtypes of Parkinson's disease (Q30418344) (← links)
- Evaluation of mild cognitive impairment subtypes in Parkinson's disease. (Q30577625) (← links)
- Tracking Parkinson's: Study Design and Baseline Patient Data (Q31008758) (← links)
- Automatic Classification on Multi-Modal MRI Data for Diagnosis of the Postural Instability and Gait Difficulty Subtype of Parkinson's Disease (Q31095916) (← links)
- Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease (Q33666297) (← links)
- Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease (Q33723751) (← links)
- Using the Montreal Cognitive Assessment Scale to screen for dementia in Chinese patients with Parkinson's Disease (Q33744548) (← links)
- Associations between cognitive impairment and motor dysfunction in Parkinson's disease (Q33810161) (← links)
- Effects of combined MAO-B inhibitors and levodopa vs. monotherapy in Parkinson's disease (Q33950517) (← links)
- Emerging topics in FXTAS. (Q34077088) (← links)
- Course of psychiatric symptoms and global cognition in early Parkinson disease (Q34198761) (← links)
- Predictors of dementia in Parkinson disease: a prospective cohort study (Q34269001) (← links)
- Neural substrates of cognitive subtypes in Parkinson's disease: a 3-year longitudinal study. (Q34374245) (← links)
- Cognition and gait show a selective pattern of association dominated by phenotype in incident Parkinson's disease (Q34382051) (← links)
- Parkinson subtypes progress differently in clinical course and imaging pattern (Q34442161) (← links)
- Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease (Q35013928) (← links)
- Morphologic changes in the mesolimbic pathway in Parkinson's disease motor subtypes (Q35582511) (← links)
- Longitudinal study of normal cognition in Parkinson disease (Q35771313) (← links)
- Cognitive impairment and dementia in Parkinson's disease: clinical features, diagnosis, and management. (Q35988441) (← links)
- Structural Brain Alterations in Motor Subtypes of Parkinson's Disease: Evidence from Probabilistic Tractography and Shape Analysis (Q36055434) (← links)
- Clinical differences among mild cognitive impairment subtypes in Parkinson's disease (Q36143993) (← links)
- Parkinson's disease dementia: a neural networks perspective (Q36186763) (← links)
- Cholinergic dysfunction contributes to gait disturbance in early Parkinson's disease (Q36218725) (← links)
- Cerebral causes and consequences of parkinsonian resting tremor: a tale of two circuits? (Q36410997) (← links)
- The spectrum of nonmotor symptoms in early Parkinson disease (Q36659353) (← links)
- Neurological gait disorders in elderly people: clinical approach and classification (Q36682463) (← links)
- Disease progress and response to treatment as predictors of survival, disability, cognitive impairment and depression in Parkinson's disease (Q36779123) (← links)
- Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. (Q36834550) (← links)
- Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease. (Q36865849) (← links)
- Gray matter atrophy distinguishes between Parkinson disease motor subtypes (Q36870270) (← links)
- Community and long-term care management of Parkinson's disease in the elderly: focus on monoamine oxidase type B inhibitors (Q36911874) (← links)
- β-Amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia (Q36924335) (← links)
- Subcortical Volumes Differ in Parkinson's Disease Motor Subtypes: New Insights into the Pathophysiology of Disparate Symptoms (Q37080947) (← links)
- Relation of Parkinson's disease subtypes to visual activities of daily living. (Q37136551) (← links)
- PINK1 mutations and parkinsonism (Q37178950) (← links)
- Physical frailty in older persons is associated with Alzheimer disease pathology (Q37179080) (← links)
- Frontal and posterior subtypes of neuropsychological deficit in Parkinson's disease (Q37283997) (← links)
- Rivastigmine for the treatment of dementia associated with Parkinson's disease (Q37418973) (← links)
- Motor phenotype and magnetic resonance measures of basal ganglia iron levels in Parkinson's disease (Q37426208) (← links)